This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2023 Sep 21;389(12):1121-1131.

doi: 10.1056/NEJMra2213296.

Prevention of Central Line-Associated Bloodstream Infections

Naomi P O'Grady¹

Affiliations

PMID: 37733310
DOI: 10.1056/NEJMra2213296

Review

Prevention of Central Line-Associated Bloodstream Infections

Naomi P O'Grady. N Engl J Med. 2023.

. 2023 Sep 21;389(12):1121-1131.

doi: 10.1056/NEJMra2213296.

Author

Naomi P O'Grady¹

Affiliation

¹ From the National Institutes of Health Clinical Center, Bethesda, MD.

PMID: 37733310
DOI: 10.1056/NEJMra2213296

No abstract available

PubMed Disclaimer

Comment in

Prevention of Central Line-Associated Bloodstream Infections.
Tardy C, Lasik E, Jacobs FM. Tardy C, et al. N Engl J Med. 2023 Dec 14;389(24):2307-2308. doi: 10.1056/NEJMc2312283. N Engl J Med. 2023. PMID: 38091549 No abstract available.
Prevention of Central Line-Associated Bloodstream Infections. Reply.
O'Grady NP. O'Grady NP. N Engl J Med. 2023 Dec 14;389(24):2308. doi: 10.1056/NEJMc2312283. N Engl J Med. 2023. PMID: 38091550 No abstract available.

References

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions